Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice

Journal of Ethnopharmacology

Volumn 171, Issue , 2015, Pages 161-170

  Yang, Xinzhou ^a,b   Yang, Jing ^a   Xu, Chan ^a   Huang, Mi ^a   Zhou, Qi ^a   Lv, Jingnan ^a   Ma, Xinhua ^a   Ke, Changqiang ^b   Ye, Yang ^b   Shu, Guangwen ^a   Zhao, Ping ^a  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

AMPK; Antidiabetic; GLUT4; KKAy mice; Off line HPLC NMR; Sophora flavescens

Indexed keywords

ADENYLATE KINASE; ANTIDIABETIC AGENT; FATTY ACID; FLAVONOID; GLUCOSE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SOPHORA FLAVESCENS EXTRACT; TRIACYLGLYCEROL; CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; KK-AY MOUSE; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; MOUSE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; RAT; SOPHORA FLAVESCENS; ANALYSIS; ANIMAL; BLOOD; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; LIPID DIET; LIVER; METABOLISM; PANCREAS; PATHOLOGY; PHYTOTHERAPY; PLANT ROOT; SKELETAL MUSCLE; SOPHORA;

MUS; SOPHORA FLAVESCENS;

ANIMALS; BLOOD GLUCOSE; CELL LINE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FATTY ACIDS, NONESTERIFIED; FEMALE; FLAVONOIDS; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; MICE; MUSCLE, SKELETAL; PANCREAS; PHYTOTHERAPY; PLANT ROOTS; RATS; SOPHORA; TRIGLYCERIDES;

EID: 84934930378     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.05.043     Document Type: Article

References (45)

1. T.M. Ahonen, J.T. Saltevo, H.J. Kautiainen, E.A. Kumpusalo, and M.J. Vanhala The association of adiponectin and low-grade inflammation with the course of metabolic syndrome Nutr. Metab. Cardiovasc. Dis. 22 2012 285 291
2. L. Bai, Y. Wang, J. Fan, Y. Chen, W. Ji, A. Qu, P. Xu, D.E. James, and T. Xu Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action Cell Metab. 5 2007 47 57
3. P. Bansal, P. Paul, J. Mudgal, P.G. Nayak, S.T. Pannakal, K.I. Priyadarsini, and M.K. Unnikrishnan Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice Exp. Toxicol. Pathol. 64 2012 651 658
4. D. Carling The AMP-activated protein kinase cascade-a unifying system for energy control Trends Biochem. Sci. 29 2004 18 24
5. B. Charbonnel, J. Dormandy, E. Erdmann, M. Massi-Benedetti, and A. Skene The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients Diabetes Care 27 2004 1647 1653
6. X.G. Du, Y.J. Bai, H. Liang, Z.Y. Wang, Y.Y. Zhao, Q.Y. Zhang, and L. Huang Solvent effect in 1H NMR spectra of 3'-hydroxy-4'-methoxy isoflavonoids from Astragalus membranaceus var. mongholicus Magn. Reson. Chem. 44 2006 708 712
7. S. Fogarty, and D.G. Hardie Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer Biochim. Biophys. Acta (BBA) - Proteins Proteomics 1804 2010 581 591
8. P.J. Goodwin, K.I. Pritchard, M. Ennis, M. Clemons, M. Graham, and I.G. Fantus Insulin-lowering effects of metformin in women with early breast cancer Clin. Breast Cancer 6 2008 501 505
9. R.E. Gosselin, R.P. Smith, and H.C. Hodge Clinical Toxicology of Commercial Products 1984 Williams and Wilkins Baltimore, London, United Kingdom
10. D.G. Hardie AMP-activated protein kinase - an energy sensor that regulates all aspects of cell function Genes Dev. 25 2011 1895 1908
11. K. He, X.G. Li, X. Chen, X.L. Ye, J. Huang, Y.N. Jin, P.P. Li, Y.F. Deng, Q. Jin, Q. Shi, and H.J. Shu Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice J. Ethnopharmacol. 137 2011 1135 1142
12. P.I. Hillerns, and M. Wink Binding of flavonoids from Sophora flavescens to the rat uterine estrogen receptor Planta Med. 71 2005 1065 1068
13. H.A. Jung, N.Y. Yoon, S.S. Kang, Y.S. Kim, and J.S. Choi Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts J. Pharm. Pharmacol. 9 2008 1227 1236
14. M. Jung, M. Park, H.C. Lee, Y.H. Kang, E.S. Kang, and S.K. Kim Antidiabetic agents from medicinal plants Curr. Med. Chem. 13 2006 1203 1218
15. E.J. Kim, S.N. Jung, K.H. Son, S.R. Kim, T.Y. Ha, and M.G. Park Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase Mol. Pharmacol. 72 2007 62 72
16. J.H. Kim, Y.B. Ryu, N.S. Kang, B.W. Lee, J.S. Heo, I.Y. Jeong, and K.H. Park Glycosidase inhibitory flavonoids from Sophora flavescens Biol. Pharm. Bull. 29 2006 302 305
17. P. Kovacs, and M. Stumvoll Fatty acids and insulin resistance in muscle and liver Best Pract. Res. Clin. Endocrinol. Metab. 19 2005 625 635
18. K. Kyogoku, K. Hatayama, and M. Komatsu Constituents of Chinese crude drug "Kushen" (the root of Sophora flavescens Ait.). Isolation of five new flavonoids and formononetin Chem. Pharm. Bull. 21 1973 2733 2738
19. Y.S. Lee, W.S. Kim, K.H. Kim, M.J. Yoon, H.J. Cho, Y. Shen, J.M. Ye, C.H. Lee, W.K. Oh, C.T. Kim, C. Hohnen-Behrens, A. Gosby, E.W. Kraegen, D.E. James, and J.B. Kim Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states Diabetes 55 2006 2256 2264
20. C. Levetan Oral antidiabetic agents in type 2 diabetes Curr. Med. Res. Opin. 23 2007 945 952
21. Z. Lian, Y. Li, J. Gao, K. Qu, J. Li, L. Hao, S. Wu, and H. Zhu A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells Lipids Health Dis. 10 2011 67
22. S.Z. Liu, Y.X. Deng, B. Chen, X.J. Zhang, Q.Z. Shi, and X.M. Qiu Antihyperglycemic effect of the traditional Chinese scutellaria-coptis herb couple and its main components in streptozotocin-induced diabetic rats J. Ethnopharmacol. 145 2013 490 498
23. Z. Lu, M. Li, J. Wang, D. Wei, Q. Liu, and L. Kong Developmental toxicity and neurotoxicity of two matrine-type alkaloids, matrine and sophocarpine, in zebrafish (Danio rerio) embryos/larvae Reprod. Toxicol. 47 2014 33 41
24. A. Moussa, and J. Li AMPK in myocardial infarction and diabetes: the yin/yang effect Acta Pharmacol. Sin. 2 2012 368 378
25. M. Okazaki, Y. Saito, Y. Udaka, M. Maruyama, H. Murakami, S. Ota, T. Kikuchi, and K. Oguchi Exp. Anim. 51 2002 191 196
26. C. Pirat, A. Farce, N. Lebègue, N. Renault, C. Furman, R. Millet, and P. Chavatte Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators J. Med. Chem. 55 2012 4027 4061
27. T.H. Quang, N.T.T. Ngan, C.V. Minh, P.V. Kiem, B.H. Tai, N.P. Thao, S.B. Song, and Y.H. Kim Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii Bioorg. Med. Chem. Lett. 22 2012 2527 2533
28. H.T. Shang, H. Wei, B.F. Yue, P. Xu, and H.G. Huang Microsatellite analysis in two populations of Kunming mice Lab. Anim. 43 2009 34 40
29. H.C. Shi, and Q.Y. Huang Studies on prevention of diabetogenous cataract by Chinese crude drug Sophora Strait Pharm. J. 11 1999 15 17
30. H.J. Shin, H.J. Kim, J.H. Kwak, H.O. Chun, J.H. Kim, H. Park, D.H. Kim, and Y.S. Lee A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5 Bioorg. Med. Chem. Lett. 12 2002 2313 2316
31. P. Shokeen, P. Anand, Y.K. Murali, and V. Tandon Antidiabetic activity of 50% ethanolic extract of Ricinus communis and its purified fractions Food Chem. Toxicol. 46 2008 3458 3466
32. J.K. Son, J.S. Park, A.K. Kim, Y.S. Kim, S.R. Chung, and S.H. Lee Prenylated flavonoids from the roots of Sophora flavescens with tyrosinase inhibitory activity Planta Med. 69 2003 559 561
33. S. Subramanian, and A. Chait Hypertriglyceridemia secondary to obesity and diabetes Biochim. Biophys. Acta 1821 2012 819 825
34. M.J. Tan, J.M. Ye, N. Turner, C. Hohnen-Behrens, C.Q. Ke, C.P. Tang, T. Chen, H.C. Weiss, E.R. Gesing, A. Rowland, D.E. James, and Y. Ye Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway Chem. Biol. 15 2008 263 273
35. N. Turner, J.Y. Li, A. Gosby, S.W. To, Z. Cheng, H. Miyoshi, M.M. Taketo, G.J. Cooney, E.W. Kraegen, D.E. James, L.H. Hu, J. Li, and J.M. Ye Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action Diabetes 5 2008 1414 1418
36. D. Vina, S. Serra, M. Lamela, and G. Delogu Herbal natural products as a source of monoamine oxidase inhibitors: a review Curr. Top. Med. Chem. 12 2012 2131 2144
37. Y.L. Wang, Z.Q. Xiao, S. Liu, L.S. Wan, Y.D. Yue, Y.T. Zhang, Z.X. Liu, and J.C. Chen Antidiabetic effects of Swertia macrosperma extracts in diabetic rats J. Ethnopharmacol. 150 2013 536 544
38. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
39. J.L. Wolfender, E.F. Queiroz, and K. Hostettmann Phytochemistry in the microgram domain - a LC-NMR perspective Magn. Reson. Chem. 43 2005 697 709
40. Yang, J., Zhao, P., Wan, D., Zhou, Q., Wang, C., Shu, G.W., Mei, Z.N., Yang, X.Z., 2014. Antidiabetic effect of methanolic extract from Berberis julianae Schneid. via activation of AMP-Activated protein kinase in type 2 diabetic mice. Evidence-Based Complementary and Alternative Medicine, 10.1155/2014/106206.
41. W. Yang, J. Lu, J. Wen, W. Jia, L. Ji, J. Xiao, Z. Shan, J. Liu, H. Tian, Q. Ji, D. Zhu, J. Ge, L. Lin, L. Chen, X. Guo, Z. Zhao, Q. Li, Z. Zhou, G. Shan, and J. He Prevalence of diabetes among men and women in China N. Engl. J. Med. 362 2010 1090 1101
42. J.M. Ye, N.B. Ruderman, and E.W. Kraegen AMP-activated protein kinase and malonyl-CoA: targets for treating insulin resistance? Drug Discov. Today: Ther. Strateg. 2 2005 157 163
43. B.B. Zhang, G. Zhou, and C. Li AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metab. 9 2009 407 416
44. C.Y. Zhang, L.E. Parton, C.P. Ye, S. Krauss, R.C. Shen, C.T. Lin, J.A. Porco Jr., and B.B. Lowell Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced β cell dysfunction in isolated pancreatic islets Cell Metab. 3 2006 417 427
45. X.L. Zhang, M.A. Cao, L.P. Pu, S.S. Huang, Q.X. Gao, C.S. Yuan, and C.M. Wang A novel flavonoid isolated from Sophora flavescens exhibited anti-angiogenesis activity, decreased VEGF expression and caused G0/G1 cell cycle arrest in vitro Pharmazie 68 2013 369 375